Articles liés à Gene Transfer in the Cardiovascular System: Experimental...

Gene Transfer in the Cardiovascular System: Experimental Approaches and Therapeutic Implications - Couverture souple

 
9781461378815: Gene Transfer in the Cardiovascular System: Experimental Approaches and Therapeutic Implications

Synopsis

The goal of gene transfer is protein expression. a process brought about by the insertion of a gene coding for a foreign protein into target cells resulting in the synthesis of the foreign protein For gene therapy, a tmnsferred therapeutic gene must be expressed at a level beneficial for the patient. This chapter provides an introductory overview of the rapidly evolving field of non-viral approaches for gene delivery to rnarnrnalian cells. Although currently there are fewer ongoing clinical trials using non-viral approaches than those using viral based systems, the number of non-viral trials is increasing. The long range goal of some research groups is the development of a genetically engineered artificial virus targeted to specific cells in the human body. An arurual conference, organized by Cambridge Healthtech Institute entitled "Artificial Self-Assembling Systems for Gene Transfer", brings together researchers interested in this field [1]. Assembly of an artificial virus is very complex; other research groups aim to develop simpler delivery systems consisting of a plasmid combined with delivery agents. Viral-based systems are very successful for gene delivery, but despite their successes, viral-based systems have some geneml limitations and system-specific limitations. When employing a viml-based system, the following limitations should be considered: - size limitation of the inserted gene due to packaging constraints (e. g. adenovirus, retrovirus) . - potential tumorigenesis (e. g. retrovirus) - potential for insertional mutagenesis (greater than plasmid based systems) - potential imrnunogenicity (e. g.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Acheter D'occasion

état :  Comme neuf
Unread book in perfect condition...
Afficher cet article
EUR 255,92

Autre devise

EUR 2,28 expédition vers Etats-Unis

Destinations, frais et délais

Acheter neuf

Afficher cet article
EUR 205,44

Autre devise

EUR 3,45 expédition vers Etats-Unis

Destinations, frais et délais

Autres éditions populaires du même titre

9780792398592: Gene Transfer in the Cardiovascular System: Experimental Approaches and Therapeutic Implications

Edition présentée

ISBN 10 :  0792398599 ISBN 13 :  9780792398592
Editeur : Kluwer Academic Publishers, 1997
Couverture rigide

Résultats de recherche pour Gene Transfer in the Cardiovascular System: Experimental...

Image d'archives

Edité par Springer, 2012
ISBN 10 : 1461378818 ISBN 13 : 9781461378815
Neuf Couverture souple

Vendeur : Lucky's Textbooks, Dallas, TX, Etats-Unis

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. N° de réf. du vendeur ABLIING23Mar2716030034306

Contacter le vendeur

Acheter neuf

EUR 205,44
Autre devise
Frais de port : EUR 3,45
Vers Etats-Unis
Destinations, frais et délais

Quantité disponible : Plus de 20 disponibles

Ajouter au panier

Image d'archives

Keith L. March
ISBN 10 : 1461378818 ISBN 13 : 9781461378815
Neuf Paperback

Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Paperback. Etat : new. Paperback. The goal of gene transfer is protein expression. a process brought about by the insertion of a gene coding for a foreign protein into target cells resulting in the synthesis of the foreign protein For gene therapy, a tmnsferred therapeutic gene must be expressed at a level beneficial for the patient. This chapter provides an introductory overview of the rapidly evolving field of non-viral approaches for gene delivery to rnarnrnalian cells. Although currently there are fewer ongoing clinical trials using non-viral approaches than those using viral based systems, the number of non-viral trials is increasing. The long range goal of some research groups is the development of a genetically engineered artificial virus targeted to specific cells in the human body. An arurual conference, organized by Cambridge Healthtech Institute entitled "Artificial Self-Assembling Systems for Gene Transfer", brings together researchers interested in this field [1]. Assembly of an artificial virus is very complex; other research groups aim to develop simpler delivery systems consisting of a plasmid combined with delivery agents. Viral-based systems are very successful for gene delivery, but despite their successes, viral-based systems have some geneml limitations and system-specific limitations. When employing a viml-based system, the following limitations should be considered: size limitation of the inserted gene due to packaging constraints (e. g. adenovirus, retrovirus) . potential tumorigenesis (e. g. retrovirus) potential for insertional mutagenesis (greater than plasmid based systems) potential imrnunogenicity (e. g. a process brought about by the insertion of a gene coding for a foreign protein into target cells resulting in the synthesis of the foreign protein For gene therapy, a tmnsferred therapeutic gene must be expressed at a level beneficial for the patient. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9781461378815

Contacter le vendeur

Acheter neuf

EUR 208,98
Autre devise
Frais de port : Gratuit
Vers Etats-Unis
Destinations, frais et délais

Quantité disponible : 1 disponible(s)

Ajouter au panier

Image fournie par le vendeur

March, Keith L.
Edité par Springer US, 2012
ISBN 10 : 1461378818 ISBN 13 : 9781461378815
Neuf Couverture souple
impression à la demande

Vendeur : moluna, Greven, Allemagne

Évaluation du vendeur 4 sur 5 étoiles Evaluation 4 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The goal of gene transfer is protein expression. a process brought about by the insertion of a gene coding for a foreign protein into target cells resulting in the synthesis of the foreign protein For gene therapy, a tmnsferred therapeutic gene must be expr. N° de réf. du vendeur 4196000

Contacter le vendeur

Acheter neuf

EUR 180,07
Autre devise
Frais de port : EUR 48,99
De Allemagne vers Etats-Unis
Destinations, frais et délais

Quantité disponible : Plus de 20 disponibles

Ajouter au panier

Image d'archives

Edité par Springer, 2012
ISBN 10 : 1461378818 ISBN 13 : 9781461378815
Neuf Couverture souple

Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. In. N° de réf. du vendeur ria9781461378815_new

Contacter le vendeur

Acheter neuf

EUR 218,14
Autre devise
Frais de port : EUR 13,78
De Royaume-Uni vers Etats-Unis
Destinations, frais et délais

Quantité disponible : Plus de 20 disponibles

Ajouter au panier

Image fournie par le vendeur

Keith L. March
Edité par Springer US Okt 2012, 2012
ISBN 10 : 1461378818 ISBN 13 : 9781461378815
Neuf Taschenbuch
impression à la demande

Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The goal of gene transfer is protein expression. a process brought about by the insertion of a gene coding for a foreign protein into target cells resulting in the synthesis of the foreign protein For gene therapy, a tmnsferred therapeutic gene must be expressed at a level beneficial for the patient. This chapter provides an introductory overview of the rapidly evolving field of non-viral approaches for gene delivery to rnarnrnalian cells. Although currently there are fewer ongoing clinical trials using non-viral approaches than those using viral based systems, the number of non-viral trials is increasing. The long range goal of some research groups is the development of a genetically engineered artificial virus targeted to specific cells in the human body. An arurual conference, organized by Cambridge Healthtech Institute entitled 'Artificial Self-Assembling Systems for Gene Transfer', brings together researchers interested in this field [1]. Assembly of an artificial virus is very complex; other research groups aim to develop simpler delivery systems consisting of a plasmid combined with delivery agents. Viral-based systems are very successful for gene delivery, but despite their successes, viral-based systems have some geneml limitations and system-specific limitations. When employing a viml-based system, the following limitations should be considered: - size limitation of the inserted gene due to packaging constraints (e. g. adenovirus, retrovirus) . - potential tumorigenesis (e. g. retrovirus) - potential for insertional mutagenesis (greater than plasmid based systems) - potential imrnunogenicity (e. g. 540 pp. Englisch. N° de réf. du vendeur 9781461378815

Contacter le vendeur

Acheter neuf

EUR 213,99
Autre devise
Frais de port : EUR 23
De Allemagne vers Etats-Unis
Destinations, frais et délais

Quantité disponible : 2 disponible(s)

Ajouter au panier

Image fournie par le vendeur

March, Keith L. (EDT)
Edité par Springer, 2012
ISBN 10 : 1461378818 ISBN 13 : 9781461378815
Neuf Couverture souple

Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. N° de réf. du vendeur 19490434-n

Contacter le vendeur

Acheter neuf

EUR 236,52
Autre devise
Frais de port : EUR 2,28
Vers Etats-Unis
Destinations, frais et délais

Quantité disponible : 15 disponible(s)

Ajouter au panier

Image fournie par le vendeur

March, Keith L. (EDT)
Edité par Springer, 2012
ISBN 10 : 1461378818 ISBN 13 : 9781461378815
Ancien ou d'occasion Couverture souple

Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 19490434

Contacter le vendeur

Acheter D'occasion

EUR 255,92
Autre devise
Frais de port : EUR 2,28
Vers Etats-Unis
Destinations, frais et délais

Quantité disponible : 15 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Keith L. March
ISBN 10 : 1461378818 ISBN 13 : 9781461378815
Neuf Taschenbuch
impression à la demande

Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The goal of gene transfer is protein expression. a process brought about by the insertion of a gene coding for a foreign protein into target cells resulting in the synthesis of the foreign protein For gene therapy, a tmnsferred therapeutic gene must be expressed at a level beneficial for the patient. This chapter provides an introductory overview of the rapidly evolving field of non-viral approaches for gene delivery to rnarnrnalian cells. Although currently there are fewer ongoing clinical trials using non-viral approaches than those using viral based systems, the number of non-viral trials is increasing. The long range goal of some research groups is the development of a genetically engineered artificial virus targeted to specific cells in the human body. An arurual conference, organized by Cambridge Healthtech Institute entitled 'Artificial Self-Assembling Systems for Gene Transfer', brings together researchers interested in this field [1]. Assembly of an artificial virus is very complex; other research groups aim to develop simpler delivery systems consisting of a plasmid combined with delivery agents. Viral-based systems are very successful for gene delivery, but despite their successes, viral-based systems have some geneml limitations and system-specific limitations. When employing a viml-based system, the following limitations should be considered: ¿ size limitation of the inserted gene due to packaging constraints (e. g. adenovirus, retrovirus) . ¿ potential tumorigenesis (e. g. retrovirus) ¿ potential for insertional mutagenesis (greater than plasmid based systems) ¿ potential imrnunogenicity (e. g.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 540 pp. Englisch. N° de réf. du vendeur 9781461378815

Contacter le vendeur

Acheter neuf

EUR 213,99
Autre devise
Frais de port : EUR 60
De Allemagne vers Etats-Unis
Destinations, frais et délais

Quantité disponible : 1 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Keith L. March
Edité par Springer US, 2012
ISBN 10 : 1461378818 ISBN 13 : 9781461378815
Neuf Taschenbuch

Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - The goal of gene transfer is protein expression. a process brought about by the insertion of a gene coding for a foreign protein into target cells resulting in the synthesis of the foreign protein For gene therapy, a tmnsferred therapeutic gene must be expressed at a level beneficial for the patient. This chapter provides an introductory overview of the rapidly evolving field of non-viral approaches for gene delivery to rnarnrnalian cells. Although currently there are fewer ongoing clinical trials using non-viral approaches than those using viral based systems, the number of non-viral trials is increasing. The long range goal of some research groups is the development of a genetically engineered artificial virus targeted to specific cells in the human body. An arurual conference, organized by Cambridge Healthtech Institute entitled 'Artificial Self-Assembling Systems for Gene Transfer', brings together researchers interested in this field [1]. Assembly of an artificial virus is very complex; other research groups aim to develop simpler delivery systems consisting of a plasmid combined with delivery agents. Viral-based systems are very successful for gene delivery, but despite their successes, viral-based systems have some geneml limitations and system-specific limitations. When employing a viml-based system, the following limitations should be considered: - size limitation of the inserted gene due to packaging constraints (e. g. adenovirus, retrovirus) . - potential tumorigenesis (e. g. retrovirus) - potential for insertional mutagenesis (greater than plasmid based systems) - potential imrnunogenicity (e. g. N° de réf. du vendeur 9781461378815

Contacter le vendeur

Acheter neuf

EUR 217,46
Autre devise
Frais de port : EUR 64,05
De Allemagne vers Etats-Unis
Destinations, frais et délais

Quantité disponible : 1 disponible(s)

Ajouter au panier

Image d'archives

March, Keith L. (Editor)
Edité par Springer Verlag, 2012
ISBN 10 : 1461378818 ISBN 13 : 9781461378815
Neuf Paperback

Vendeur : Revaluation Books, Exeter, Royaume-Uni

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Paperback. Etat : Brand New. reprint edition. 538 pages. 9.25x6.10x1.09 inches. In Stock. N° de réf. du vendeur x-1461378818

Contacter le vendeur

Acheter neuf

EUR 304,31
Autre devise
Frais de port : EUR 28,76
De Royaume-Uni vers Etats-Unis
Destinations, frais et délais

Quantité disponible : 2 disponible(s)

Ajouter au panier

There are 1 autres exemplaires de ce livre sont disponibles

Afficher tous les résultats pour ce livre